Richard J. Rodgers
CIK: 0001313397
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 20, 2026NVAX
NOVAVAX INC
Exercise(M)Direct18.9K shares- - Jun 18, 2026NVAX
NOVAVAX INC
Award(A)DirectRestricted Stock Units
14.2K shares- - Jun 18, 2026NVAX
NOVAVAX INC
Award(A)DirectStock Option (Right to Buy)
21.3K shares- - Jun 16, 2026ARDX
ARDELYX, INC.
Award(A)Direct26.5K shares- - Apr 20, 2026IRD
Opus Genetics, Inc.
Award(A)Direct24.4K shares- - Oct 29, 2025NVAX
NOVAVAX INC
Exercise(M)Direct3.8K shares- - Jun 20, 2025NVAX
NOVAVAX INC
Award(A)DirectRestricted Stock Units
18.9K shares- - Jun 20, 2025NVAX
NOVAVAX INC
Award(A)DirectStock Option (Right to Buy)
28.3K shares at avg. $6.42- - Jun 18, 2025ARDX
ARDELYX, INC.
Award(A)Direct21.5K shares- - Jun 18, 2025ARDX
ARDELYX, INC.
Award(A)Direct41.6K shares- - Jun 12, 2025NVAX
NOVAVAX INC
Exercise(M)Direct10.4K shares- - Apr 30, 2025IRD
Opus Genetics, Inc.
Award(A)Direct79.5K shares- - Jan 16, 2025ARDX
ARDELYX, INC.
Exercise(M)Direct100K shares at avg. $0.55$55K - Oct 29, 2024NVAX
NOVAVAX INC
Exercise(M)Direct3.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 20, 2026 |  NVAX NOVAVAX INC | Exercise(M) | 18,880 | - | $0 | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award(A) Restricted Stock Units | 14,180 | - | - | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award(A) Stock Option (Right to Buy) | 21,270 | - | - | Direct |
| Jun 16, 2026 |  ARDX ARDELYX, INC. | Award(A) | 26,455 | - | $0 | Direct |
| Apr 20, 2026 |  IRD Opus Genetics, Inc. | Award(A) | 24,367 | - | $0 | Direct |
| Oct 29, 2025 | NVAX NOVAVAX INC | Exercise(M) | 3,800 | - | - | Direct |
| Jun 20, 2025 | NVAX NOVAVAX INC | Award(A) Restricted Stock Units | 18,884 | - | - | Direct |
| Jun 20, 2025 | NVAX NOVAVAX INC | Award(A) Stock Option (Right to Buy) | 28,326 | $6.42 | - | Direct |
| Jun 18, 2025 | ARDX ARDELYX, INC. | Award(A) | 21,468 | - | - | Direct |
| Jun 18, 2025 | ARDX ARDELYX, INC. | Award(A) | 41,551 | - | - | Direct |
| Jun 12, 2025 | NVAX NOVAVAX INC | Exercise(M) | 10,420 | - | - | Direct |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | Award(A) | 79,504 | - | - | Direct |
| Jan 16, 2025 | ARDX ARDELYX, INC. | Exercise(M) | 100,000 | $0.55 | $55,000 | Direct |
| Oct 29, 2024 | NVAX NOVAVAX INC | Exercise(M) | 3,800 | - | $0 | Direct |
1-14 of 14 transactions
About Rodgers Richard J
Rodgers Richard J (SEC CIK 0001313397) files insider reports with the SEC as Director of NOVAVAX INC (NVAX), Director of ARDELYX, INC. (ARDX) and Director of Opus Genetics, Inc. (IRD).
Signal8 holds 10 ownership filings by Rodgers Richard J, all Form 4s, filed between Jan 2, 2025 and Jun 23, 2026. Those filings report 14 transactions, from Oct 29, 2024 to Jun 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rodgers Richard J's filings is in WALTHAM, MA.
Recent filings by Rodgers Richard J
- Jun 20, 2026: Option exercise of NVAX shares (Form 4, code M).
- Jun 18, 2026: Grants or awards of NVAX derivative securities (2 lines, Form 4, code A).
- Jun 16, 2026: Grant or award of ARDX shares (Form 4, code A).
- Apr 20, 2026: Grant or award of IRD shares (Form 4, code A).
- Oct 29, 2025: Option exercise of NVAX shares (Form 4, code M).
Other insiders filing for NOVAVAX INC (NVAX)
- King Rachel K., Director
- DOUGLAS RICHARD, Director
- MCGLYNN MARGARET G, Director
- MOTT DAVID M, Director
- Alton Gregg H, Director
- Shiver John W., Director